Product Code: RP-ID-10008306 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10008306
Market Overview:
Urinalysis Test Market Analysis by End User (Research Laboratories, Hospitals & Clinics, Home Care Settings, and Others); by Application (Pregnancy & Fertility, Kidney Disease, and Disease Screening); and by Testing Type (Biochemical Urinalysis, Pregnancy & Fertility Tests, Sediment Urinalysis, and Others)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Definition of Urinalysis Test Market
A urinalysis test refers to a urine analysis. It is used to detect and treat a wide range of conditions, including urinary tract infections, kidney disease, and diabetes. A urine sample is used in a medical process called a urinalysis to diagnose illnesses. Protein levels, bacteria, blood cells, and other disorders including diabetes, conditions that are harmful to the liver, infections of the urinary system, etc. are all detected in the samples. The major testing types are divided into biochemical urinalysis, pregnancy & fertility tests, sediment urinalysis, and others
Global Urinalysis Test Market: Key Insights
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~ USD 1.5 Billion |
|
Forecast Year Market Size (2033) |
~ USD 4.0 Billion |
|
Regional Scope |
|
Global Urinalysis Test Market Highlights Over 2023 - 2033
The global urinalysis test market is estimated to garner a revenue of USD 8.0 Billion by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 4.0 Billion in the year 2022. The growth of the market can be attributed to the increasing incidence of death rates followed by a rise in the number of diabetes patients. Furthermore, a urinalysis test is recommended by doctors for diabetes patients who exhibit symptoms. As per the World Health Organization, the mortality rate has raised by 3 percent from 2000 to 2019 owing to diabetes.
GET A SAMPLE COPY OF THIS REPORT
A urinalysis test refers to urine analysis. It is used to detect and treat a wide range of conditions, including urinary tract infections, kidney disease, and diabetes. The primary testing types are divided into biochemical urinalysis, pregnancy & fertility tests, sediment urinalysis, and others. More, the high prevalence of urinary infections is projected to boost the growth of the global urinalysis test market. For instance, the number of urinary tract infections has increased from 1990 to 2019 accounting from more than 250 Million to more than 400 Million.
Global Urinalysis Test Market: Growth Drivers and Challenges
Growth Drivers
-
Surging Chronic Kidney Diseases– Urinalysis test help to detect a variety of kidney disorders and it is expected to drive the growth of the global urinalysis test market. According to the Centers for Disease Control and Prevention, more than one in seven or 37 Million people are suffering from chronic kidney diseases.
-
Rising Geriatric Population – As per the United Nations, there are approximately 703 Million people aged 65 years or over in the year 2019 across the globe.
-
The surge in Liver Disease Cases– According to the World Health Organization, the number of liver disease death cases in India in the year 2020 has reached 268,580.
-
Increasing Pregnancy Test– As per the World Bank, there has been a global fertility rate accounting for 2.4 (births per woman) in the year 2020.
Challenges
-
Lack of Awareness
-
High Cost for the Testing
-
Lack of Skilled Professionals for Conducting the Test
The urinalysis test should be conducted by a professional who has proper knowledge related to the storage of urine. If all the procedures are not followed when collecting urine from the patients it may result in false positives. Hence, a lack of skilled professionals for conducting the test can hamper the growth of the market.
The global urinalysis test market is segmented and analyzed for demand and supply by end-users in research laboratories, hospitals & clinics, home care settings, and others. Out of these, the hospitals & clinics segment is anticipated to hold the largest share over the forecast period owing to the rising number of hospitals, followed by an increasing test for kidney disease. According to the American Hospital Association, there has been an increase in the number of hospitals accounting for 6,093 in the year 2020.
Global Urinalysis Test Market Regional Synopsis
The Asia Pacific region market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035 on the back of its high population base, and a rise in the cases of chronic diseases. Moreover, a large number of people are going for urinalysis tests to detect the cause of the problem in their bodies. According to the World Bank, India and China’s populations have increased from 1.06 Billion and 1.26 Billion in 2000 to 1.30 Billion and 1.41 Billion in 2021.
Market Segmentation
Our in-depth analysis of the global urinalysis test market includes the following segments:
|
By End User |
|
|
By Application |
|
|
By Testing Type |
|
Customize this Report: Request Customization
Key Companies Dominating the Global Urinalysis Test Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global urinalysis test market that are included in our report are Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories Inc., General Electric Company, Cardinal Health, Sysmex Corporation, F.Hoffmann-La Roche Ltd, BioMaxima SA, ACON Laboratories, Inc., Quidel Corporation, and others.
Global Urinalysis Test Market: Latest Developments
-
January 2019: Bio-Rad Laboratories Inc., announced the launch of qUAntify Advance Control for use in clinical labs to perform urinalysis testing.
-
January 2020: Sysmex Corporation announced the investment in Astrego Diagnostics for developing new urinalysis solutions for the primary care business.
- Abbott
- Thermo Fisher Scientific
- Bio-Rad Laboratories Inc.
- General Electric Company
- Cardinal Health
- Sysmex Corporation
- F.Hoffmann-La Roche Ltd
- BioMaxima SA
- ACON Laboratories Inc.
- Quidel Corporation
Related Reports
Proof of Quality & Reliability
